6640--598-26-4-6701-0095 Illumina NextSeq 2000 and DRAGEN POP…

DISCLAIMER: THIS IS A SOURCE SOUGHT NOTICE ONLY. THIS SYNOPSIS IS NOT A REQUEST FOR QUOTE, PROPOSAL, OR BID. This notice is not a solicitation as defined by FAR 2.101, therefore it shall not be construed as a commitment by the Government to enter into a contract, nor does it restrict the Government to an acquisition approach. All information contained in this RFI is preliminary as well as subject to modification and is in no way binding on the Government. Information submitted in response to this notice is voluntary; the Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the Government. The Government is requesting that restrictive or proprietary markings not be used in response to this notice. If a solicitation is released, it is will be synopsized in the Federal Business Opportunities (FedBizOpps) website or GSA. It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this RFI. The anticipated Small Business Administration (SBA) size standard for the North American Classification code (NAICS) 334516 is 1,000 employees. 1. Purpose: The Central Arkansas Veterans Healthcare System (CAVHS) hereby issues the following Sources Sought Notice as a Request for Information (RFI). This RFI is being used for Market Research purposes only to seek contractors with the capability to provide the Central Arkansas Veterans Healthcare System (CAVHS) with all labor, tools materials, supplies, equipment, cabling, licensing, personnel, supervision and transportation required to provide the Illumina NextSeq 2000 Sequencer, DRAGEN Server, Installation and Training IAW attached draft Statement of Work. 2. Place of Performance: Central Arkansas Veterans Healthcare System 4300 West 7th Street Little Rock, AR 72205 3. Opportunity: CAVHS is seeking information from potential contractors on their ability to provide this service. THIS IS A REQUEST FOR INFORMATION (RFI) ONLY. Small Business Concerns are encouraged to provide responses to this RFI to assist the CAVHS in determining potential levels of competition available in the industry. NOTE: All Questions and information shall be answered and provided in Sections 4 through 7 for the government to consider whether the contractor has the capability to meet the government re 4. Instructions and Response Guidelines: RFI responses are due by 3PM (CST) on Monday, July 13, 2026; size is limited to 8.5 x 11 inches, 12-point font, with 1-inch margins in Microsoft Word format via email to joseph.warren@va.gov All Questions shall be submitted by 10:00am (CST) on Monday July 10, 2026 via email to joseph.warren@va.gov Telephone requests or inquires will not be accepted. The subject line shall read: 36C25626Q0961 Illumina NextSeq 2000 NO SOLICITATION EXISTS AT THIS TIME. There is no page limitation on subparagraphs 4(a) - 4(f). All Questions shall be answered to be considered as part of the Market Research for capable contractors to meet the government requirements. 11. Contact Information: Contracting Officer, Joseph Warren Email address: joseph.warren@va.gov Your responses to this notice is appreciated. SCOPE OF WORK AND GENERAL SPECIFICATIONS For Purchase of NextSeq 2000 Sequencer and DRAGEN Server DRAFT Purpose of this Contract: Execute a Firm-Fixed price contract for an Illumina NextSeq 2000 Sequencer, DRAGEN Server, Installation and Training, Service Agreements post 1-year warranties Background: The PAL was established in 2007 by the Cooperative Studies Program, Veterans Affairs (Washington, DC) as a high-throughput genomic laboratory for clinical studies implemented by CSP physicians and other VA investigators. A few of the priorities for CSP and PAL are clinical research projects on Neurodegenerative Disorders, Cardiovascular Disease, Environmental Exposures and Cancer. PAL will support a Cooperative Studies Program initiative evaluating clinical implementation of coronary heart disease (CHD) polygenic risk scores through whole exome sequencing of thousands of Veterans DNA samples. The laboratory s current Illumina MiSeq is near end of life and cannot meet the required sequencing throughput. PAL is also supporting ongoing transcriptomics research from the Durham VA MIRECC (Mental Illness Research, Education, and Clinical Center) in Veterans with Suicide Ideation, exposure to environmental toxins, PTSD and Traumatic Brain Illness. The NextSeq 2000 provides substantially higher output (up to 540 Gb, 1.8B reads) compared with the MiSeq (up to 30 Gb, 100M reads) and is better suited for large scale genomic applications. While the MiSeq offers flexible 2×300 bp read lengths for smaller projects, the NextSeq 2000 provides faster, high capacity workflows using P4 reagents and integrated informatics. The optional DRAGEN server supports secure on site analysis without cloud dependency. Contract shall include the following instrumentation